Attached files
file | filename |
---|---|
8-K - FORM 8-K - WebMD Health Corp. | g27807e8vk.htm |
EX-99.4 - EX-99.4 - WebMD Health Corp. | g27807exv99w4.htm |
EX-99.1 - EX-99.1 - WebMD Health Corp. | g27807exv99w1.htm |
EX-99.3 - EX-99.3 - WebMD Health Corp. | g27807exv99w3.htm |
Exhibit 99.2
WEBMD HEALTH CORP.
CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share data, unaudited)
CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share data, unaudited)
Three Months Ended | Six Months Ended | |||||||||||||||
June 30, | June 30, | |||||||||||||||
2011 | 2010 | 2011 | 2010 | |||||||||||||
Revenue |
$ | 141,369 | $ | 122,707 | $ | 272,978 | $ | 230,737 | ||||||||
Cost of operations |
51,152 | 45,368 | 99,601 | 88,362 | ||||||||||||
Sales and marketing |
32,270 | 29,425 | 64,564 | 57,832 | ||||||||||||
General and administrative |
22,006 | 20,577 | 44,827 | 39,386 | ||||||||||||
Depreciation and amortization |
6,724 | 6,318 | 13,148 | 13,333 | ||||||||||||
Interest income |
51 | 420 | 67 | 3,829 | ||||||||||||
Interest expense |
5,833 | 3,170 | 8,974 | 8,309 | ||||||||||||
Loss on convertible notes |
| 11,011 | | 14,738 | ||||||||||||
Gain (loss) on investments |
1,769 | 6,002 | 15,829 | (22,846 | ) | |||||||||||
Other income (expense), net |
| 99 | (53 | ) | (199 | ) | ||||||||||
Income (loss) from continuing operations before income tax
provision (benefit) |
25,204 | 13,359 | 57,707 | (10,439 | ) | |||||||||||
Income tax provision (benefit) |
11,003 | 5,675 | 23,961 | (14,333 | ) | |||||||||||
Income from continuing operations |
14,201 | 7,684 | 33,746 | 3,894 | ||||||||||||
Income from discontinued
operations, net of tax |
7,394 | | 7,394 | | ||||||||||||
Net income |
$ | 21,595 | $ | 7,684 | $ | 41,140 | $ | 3,894 | ||||||||
Basic income per common share: |
||||||||||||||||
Income from continuing operations |
$ | 0.24 | $ | 0.14 | $ | 0.58 | $ | 0.07 | ||||||||
Income from discontinued operations |
0.13 | | 0.12 | | ||||||||||||
Net income |
$ | 0.37 | $ | 0.14 | $ | 0.70 | $ | 0.07 | ||||||||
Diluted income per common share: |
||||||||||||||||
Income from continuing operations |
$ | 0.23 | $ | 0.13 | $ | 0.55 | $ | 0.07 | ||||||||
Income from discontinued operations |
0.13 | | 0.13 | | ||||||||||||
Net income |
$ | 0.36 | $ | 0.13 | $ | 0.68 | $ | 0.07 | ||||||||
Weighted-average shares outstanding used in
computing income per common share: |
||||||||||||||||
Basic |
58,096 | 53,521 | 58,140 | 52,856 | ||||||||||||
Diluted |
60,236 | 62,504 | 60,473 | 57,272 | ||||||||||||
WEBMD HEALTH CORP.
CONSOLIDATED SUPPLEMENTAL FINANCIAL INFORMATION
(In thousands, unaudited)
CONSOLIDATED SUPPLEMENTAL FINANCIAL INFORMATION
(In thousands, unaudited)
Three Months Ended | Six Months Ended | |||||||||||||||
June 30, | June 30, | |||||||||||||||
2011 | 2010 | 2011 | 2010 | |||||||||||||
Revenue |
||||||||||||||||
Public portal advertising and sponsorship |
$ | 121,108 | $ | 100,592 | $ | 231,471 | $ | 186,849 | ||||||||
Private portal services |
20,261 | 22,115 | 41,507 | 43,888 | ||||||||||||
$ | 141,369 | $ | 122,707 | $ | 272,978 | $ | 230,737 | |||||||||
Earnings before interest, taxes, non-cash
and other items (Adjusted EBITDA) (a) |
$ | 45,289 | $ | 34,301 | $ | 83,147 | $ | 59,958 | ||||||||
Interest, taxes, non-cash and other items (b) |
||||||||||||||||
Interest income |
51 | 420 | 67 | 3,829 | ||||||||||||
Interest expense |
(5,833 | ) | (3,170 | ) | (8,974 | ) | (8,309 | ) | ||||||||
Income tax (provision) benefit |
(11,003 | ) | (5,675 | ) | (23,961 | ) | 14,333 | |||||||||
Depreciation and amortization |
(6,724 | ) | (6,318 | ) | (13,148 | ) | (13,333 | ) | ||||||||
Non-cash stock-based compensation |
(9,348 | ) | (6,964 | ) | (19,161 | ) | (14,801 | ) | ||||||||
Loss on convertible notes |
| (11,011 | ) | | (14,738 | ) | ||||||||||
Gain (loss) on investments |
1,769 | 6,002 | 15,829 | (22,846 | ) | |||||||||||
Other income (expense), net |
| 99 | (53 | ) | (199 | ) | ||||||||||
Income from continuing operations |
14,201 | 7,684 | 33,746 | 3,894 | ||||||||||||
Income from discontinued operations, net of tax |
7,394 | | 7,394 | | ||||||||||||
Net income |
$ | 21,595 | $ | 7,684 | $ | 41,140 | $ | 3,894 | ||||||||
(a) | See Annex A-Explanation of Non-GAAP Financial Measures. | |
(b) | Reconciliation of Adjusted EBITDA to net income. |
WEBMD HEALTH CORP.
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, unaudited)
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, unaudited)
June 30, 2011 | December 31, 2010 | |||||||
Assets |
||||||||
Cash and cash equivalents |
$ | 1,145,061 | $ | 400,501 | ||||
Accounts receivable, net |
115,214 | 134,448 | ||||||
Prepaid expenses and other current
assets |
17,913 | 12,161 | ||||||
Deferred tax assets |
21,527 | 23,467 | ||||||
Total current assets |
1,299,715 | 570,577 | ||||||
Property and equipment, net |
58,290 | 61,516 | ||||||
Goodwill |
202,104 | 202,104 | ||||||
Intangible assets, net |
21,313 | 22,626 | ||||||
Deferred tax assets |
63,827 | 71,125 | ||||||
Other assets |
33,420 | 14,254 | ||||||
Total Assets |
$ | 1,678,669 | $ | 942,202 | ||||
Liabilities and Stockholders Equity |
||||||||
Accrued expenses |
$ | 56,701 | $ | 53,181 | ||||
Deferred revenue |
95,999 | 97,043 | ||||||
Liabilities of discontinued operations |
4,804 | 17,327 | ||||||
Total current liabilities |
157,504 | 167,551 | ||||||
2.25% convertible notes due 2016 |
400,000 | | ||||||
2.50% convertible notes due 2018 |
400,000 | | ||||||
Other long-term liabilities |
22,401 | 21,756 | ||||||
Stockholders equity |
698,764 | 752,895 | ||||||
Total Liabilities and Stockholders
Equity |
$ | 1,678,669 | $ | 942,202 | ||||
WEBMD HEALTH CORP.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands, unaudited)
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands, unaudited)
Six Months Ended | ||||||||
June 30, | ||||||||
2011 | 2010 | |||||||
Cash flows from operating activities: |
||||||||
Net income |
$ | 41,140 | $ | 3,894 | ||||
Adjustments
to reconcile consolidated net income to net cash provided by operating activities: |
||||||||
Income from discontinued operations, net of tax |
(7,394 | ) | | |||||
Depreciation and amortization |
13,148 | 13,333 | ||||||
Non-cash interest, net |
1,599 | 3,885 | ||||||
Non-cash stock-based compensation |
19,161 | 14,801 | ||||||
Deferred income taxes |
4,423 | (27,729 | ) | |||||
Loss on convertible notes |
| 14,738 | ||||||
(Gain) loss on investments |
(15,829 | ) | 22,846 | |||||
Changes in operating assets and liabilities: |
||||||||
Accounts receivable |
19,234 | 13,248 | ||||||
Prepaid expenses and other, net |
(2,103 | ) | (2,144 | ) | ||||
Accrued expenses and other long-term liabilities |
4,765 | (4,801 | ) | |||||
Deferred revenue |
(1,044 | ) | 14,596 | |||||
Net cash provided by continuing operations |
77,100 | 66,667 | ||||||
Net cash used in discontinued operations |
(136 | ) | (15,501 | ) | ||||
Net cash provided by operating activities |
76,964 | 51,166 | ||||||
Cash flows from investing activities: |
||||||||
Proceeds from sales of available-for-sale securities |
| 361,852 | ||||||
Proceeds received from ARS option |
16,561 | 354 | ||||||
Purchases of property and equipment |
(9,557 | ) | (9,719 | ) | ||||
Finalization of sale price of discontinued operations |
| (1,430 | ) | |||||
Net cash provided by investing activities |
7,004 | 351,057 | ||||||
Cash flows from financing activities: |
||||||||
Proceeds from exercise of stock options |
25,053 | 48,114 | ||||||
Cash used for withholding taxes due on stock-based awards |
(6,632 | ) | (39,728 | ) | ||||
Net proceeds from issuance of the 2.50% Notes and 2.25% Notes |
774,745 | | ||||||
Repurchases of 1.75% Notes and 3 1/8% Notes |
| (81,362 | ) | |||||
Purchases of treasury stock |
(150,417 | ) | (264,527 | ) | ||||
Excess tax benefit on stock-based awards |
17,843 | 10,219 | ||||||
Net cash provided by (used in) financing activities |
660,592 | (327,284 | ) | |||||
Net increase in cash and cash equivalents |
744,560 | 74,939 | ||||||
Cash and cash equivalents at beginning of period |
400,501 | 459,766 | ||||||
Cash and cash equivalents at end of period |
$ | 1,145,061 | $ | 534,705 | ||||
WEBMD HEALTH CORP.
NET INCOME PER COMMON SHARE
(In thousands, except per share data, unaudited)
NET INCOME PER COMMON SHARE
(In thousands, except per share data, unaudited)
Three Months Ended | Six Months Ended | |||||||||||||||
June 30, | June 30, | |||||||||||||||
2011 | 2010 | 2011 | 2010 | |||||||||||||
Numerator: |
||||||||||||||||
Income from continuing operations |
$ | 14,201 | $ | 7,684 | $ | 33,746 | $ | 3,894 | ||||||||
Effect of participating non-vested restricted stock |
(91 | ) | (88 | ) | (255 | ) | (50 | ) | ||||||||
Income from continuing operations- Basic |
14,110 | 7,596 | 33,491 | 3,844 | ||||||||||||
Interest expense on 1.75% Notes, net of tax |
| 592 | | | ||||||||||||
Income from continuing operations- Diluted |
$ | 14,110 | $ | 8,188 | $ | 33,491 | $ | 3,844 | ||||||||
Income from discontinued operations, net of tax |
$ | 7,394 | $ | | $ | 7,394 | $ | | ||||||||
Effect of participating non-vested restricted stock |
(47 | ) | | (56 | ) | | ||||||||||
Income from discontinued operations, net of tax Basic and Diluted |
$ | 7,347 | $ | | $ | 7,338 | $ | | ||||||||
Denominator: |
||||||||||||||||
Weighted-average shares Basic |
58,096 | 53,521 | 58,140 | 52,856 | ||||||||||||
Employee stock options and restricted stock |
2,140 | 3,848 | 2,333 | 4,416 | ||||||||||||
1.75% Notes |
| 5,135 | | | ||||||||||||
Adjusted weighted-average shares after assumed conversions Diluted |
60,236 | 62,504 | 60,473 | 57,272 | ||||||||||||
Basic income per common share: |
||||||||||||||||
Income from continuing operations |
$ | 0.24 | $ | 0.14 | $ | 0.58 | $ | 0.07 | ||||||||
Income from discontinued operations |
0.13 | | 0.12 | | ||||||||||||
Net income |
$ | 0.37 | $ | 0.14 | $ | 0.70 | $ | 0.07 | ||||||||
Diluted income per common share: |
||||||||||||||||
Income from continuing operations |
$ | 0.23 | $ | 0.13 | $ | 0.55 | $ | 0.07 | ||||||||
Income from discontinued operations |
0.13 | | 0.13 | | ||||||||||||
Net income |
$ | 0.36 | $ | 0.13 | $ | 0.68 | $ | 0.07 | ||||||||